Clinical Hematopathology

Under the direction of Dr. Anne Avery, the mission of the Clinical Hematopathology Laboratory (formerly Clinical Immunology) is to aid veterinarians in the accurate diagnosis of hematologic malignancies, and to further our understanding of these diseases in canine and feline patients. They have provided diagnostic testing services since 2002, and in 2019 tested samples from more than 13,500 unique canine and feline patients from over 2,700 clinics. These cases, and the follow up information generously provided by submitting clinics, has helped to better define breed trends in lymphoma and leukemia, factors involved in prognosis, and to identify parallels between human and canine lymphoma.



  • Immunophenotyping and cell surface markers
    • DNA from ~ 50,000 immunophenotyped canine lymphomas and leukemias
  • PCR based immunodiagnostics
  • Clonality assessment using a variety of assays
  • c-kit mutation detection – canine mast cell tumors
  • Gene expression profiling
  • Dedicated board certified pathologist with expertise in hematopathology


  • Process >200 samples for immunophenotyping/week
  • 7 dedicated full-time technicians and 3 research scientists devoted to research and service


  • MoFlo cell sorter
    • 3 lasers, 9 colors, 4-way sort capability
  • Gallios flow cytometer
    • 3 lasers, 9 colors
  • ABI 3100 Genetic Analyzer

About Dr. Avery

Dr. Avery received her V.M.D. from the University of Pennsylvania and a Ph.D. in Immunology from Cornell University. She was a post-doctorate fellow at the Dana-Farber Cancer Institute, Harvard Medical School, and is currently a professor of immunology at Colorado State University, as well as the Director of the Clinical Hematopathology Laboratory.

NCBI Publication Listing


Dr. Anne Avery
Dr. Anne Avery

Director, Clinical Hematopathology Laboratory
Professor, Microbiology, Immunology, and Pathology

flint animal cancer center newsletter

join our community

Be among the first to learn the latest Flint Animal Cancer Center news and pet cancer treatment information.
  • This field is for validation purposes and should be left unchanged.